Want to join the conversation?
Wolfe Research analyst Steve Fleishman questions $SO whether there are other stuffs in the other revenue effects or if it's just rate relief. CFO Art Beattie says that other revenue effects are really just rate changes across the company's service territory.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?